#affordablemedicine
Breast Cancer Drug Plea Delay Draws Supreme Court Action
A breast cancer patient died before the Kerala High Court could decide her petition seeking a reduction in the price of a life-saving medicine, even though the case had been listed 57 times. The Supreme Court has now taken suo motu cognisance of the delay and issued notice to the Centre. Cancer Drug Plea Remained Pending for Nearly Four Years The petition was filed in the Kerala High Court in June 2022 by a woman undergoing treatment for b
Breast Cancer Drug Plea Delay Draws Supreme Court Action
A breast cancer patient died before the Kerala High Court could decide her petition seeking a reduction in the price of a life-saving medicine, even though the case had been listed 57 times. The Supreme Court has now taken suo motu cognisance of the delay and issued notice to the Centre. Cancer Drug Plea Remained Pending for Nearly Four Years The petition was filed in the Kerala High Court in June 2022 by a woman undergoing treatment for b
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp









